Boost ROI through strategic CMO alliances, high-density cell culture and automation to improve scalability, vector yields, workflow efficiency and market positioning.Dublin, Oct. 20, 2026 (GLOBE ...
Brazilian researchers have found that a BCL-2 promoter variant influences protein expression in bladder tumors while a ...
Temab-A plus bevacizumab: 30% response rate and 14.7-month median survival in a 30-patient Phase 1 colorectal cancer study; ...
Ageing begins long before it shows in the mirror – deep inside our cells! But research also shows that we can influence the ...
A single next-generation sequencing panel covering 116 cancer-related genes matches the traditional multi-platform approach ...
The new tool could help pinpoint the DNA changes behind hereditary diseases—a crucial step toward genetic medicines.
Scribe Therapeutics is initiated with a buy rating, targeting the in-vivo gene therapy market for cardiometabolic diseases.
ORANGE, CA / ACCESS Newswire / October 15, 2026 / Unlike most cancers, endometrial cancer is rising in incidence and ...
A machine learning-based gene expression clock helped identify SRSF1 as a rejuvenation target. The gene shifted several aging ...
New testing combines data about a patient and their tumour with artificial intelligence (AI) to build the fullest picture of ...
October 7, 2026, 10:01 to October 14, 2026, 10:01 (JST)This week saw developments in FDA Fast Track designation for a ...